Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside

World Journal of Urology

Volumn 19, Issue 5, 2001, Pages 344-350

  Truss, Michael C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Incontinence ; Phosphodiesterase ; Smooth muscle

Indexed keywords

PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE; URINARY TRACT; URINARY TRACT DISEASE;

HUMAN; MUSCLE, SMOOTH; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; URINARY TRACT; UROLOGIC DISEASES;

EID: 0035512476     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450100221     Document Type: Article

References (26)

1. 1. Andersson KE, Cardozo LD, Chappie C, Drutz HP, Finkbeiner AE, Haab F, Vela Navarete R (1999) Pharmacological treatment of urinary incontinence. In: Abrams P. Khoury S, Wein A (eds) Incontinence. Health Publication Ltd., Plymouth UK. pp 449186
2. Andersson KE, Appell R, Cardozo LD, Chappie C, Drutz HP, Finkbeiner AE, Haab F, Vela Navarete R (1999) The pharmacological treatment of urinary incontinence. Br .1 Urol Int 84: 923-947
3. Andersson K E (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45(3): 253-308
4. Eglen RM, Hedge SS, Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev 48: 531-565
5. Hadjiev D, Yancheva S (1976) Rheoencephalographic and psychological studies with ethyl apovincamate in cerebral vascular insufficiency. Arzneimittelforschung 26: 1947-1950
6. Hall IP (1993) Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses. Br J Clin Pharmacol 35(1): 17
7. Miyazaki M (1995) The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases. Angiology 46: 53-56
8. Nicholson CD, Challiss RA, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sei 12(1): 19-27
9. Page C, Torphy T (2000) PDE inhibitors: drugs with an expanding range of therapeutic uses (abstract book). William Harvey Research Conference, Nice. France 1-3 December
10. Schudt C, Dent G, Rabe K F (1996) Phosphodiesterase inhibitors. In: Page E (ed) The handbook of immunopharmacology. Academic Press, London
11. Soderling SH, Bayuga S.I, Beavo JA (1999) Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sei USA 96: 7071-7076
12. Somlyo AP, Somlyo AV (1994) Signal transduction and regulation in smooth muscle. Nature 372: 231-236
13. Taher A, Schulz-Knappe P, Meyer M, et al (1994) Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World .1 Urol 12: 286 291
14. Thai LJ. Salmon DP. Lasker B. Bower D. Klauber MR (1989) The safety and lack of efficiency of vinpocetine in Alzheimers disease. J Am Geriatr Soc 37: 515-520
15. Thiemann Pharmaceuticals (1994) Vinpocetine product information
16. Truss MC. Ückert S. Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U (1995) Porcine detrusor cyclic nucleotide phosphodiesterase (PDE) isoenzymes: characterization and functional effects of various PDE inhibitors in vitro. Urology 45(5): 893-901
17. Truss MC, Ückert S, Stief CG, Kuczyk M, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle: I. Identification and characterization. Urol Res 24: 123-128
18. Truss MC, Ückert S, Stief CG, Forssmann WG, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle: II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res 24: 129-134
19. Truss MC, Ückert S, Stief CG, Kuczyk M, Schulz-Knappe, Forssmann WG, Jonas U (1996) Effects of various phosphodiesterase-inhibitors, forskolin and sodium nitroprusside on porcine detrusor smooth muscle tone and cyclic nucleotide levels in vitro. Neurourol Urodyn 15: 59-70
20. Truss MC, Becker AJ. Ückert S, Schultheiss D. Machtens S, Jonas U, Stief CG (1999) Selective pharmacological manipu-
21. lution of the smooth muscle tissue of the GLJ-truct. Br J Urol Int 83 [Suppl]: 36-1
22. Truss MC. Stief CG, Ückert S. Becker A3, Schultheiss D. Machtens S, Jonas U (2000) Initial clinical experience with the selective phosphodiesterase (PDE) I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder. World J Urol 18: 439 443
23. Truss MC, Stief CG. Ückert S, Becker A.I. Schultheiss D. Hagemann J, Jonas U (2001) Phosphodiesterase 1 inhibition in
24. the treatment of urinary urgency and urge incontinence results of the vinpocetinc multicenter trial. 16th Congress of theEuropean Association of Urology. Geneva. April 7 10, 2001. Eur Urol 39(S5): A5I2
25. Ückert S. Küthe A, Stief CG Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes from the human prostate. J Urol (in press)
26. Wagner TH, Hu TW (1998) Economic costs of urinary incontinence in 1995. Urology 51: 355 361